Today on the program you’ll hear an interview with Ellis and Paul Gill, CEO of Lomiko Metals, trading as LMR on the TSX Venture Exchange and LMRMF on the OTC. Lomiko has a vertical integration strategy to develop graphite and graphene production and products. Dr. Brad Thompson of Oncolytics Biotech trading as ONC on the TSX and ONCY on the OTCQX. Brad and Ellis will discuss the probability that cancer will become an affliction of the past as we near a cure. You’ll hear from Nobilis Health trading in the US as HLTH and on the TSX as NHC. Ellis will visit with the raving capitalist Paul Mladjeno
|